Form 4: Pfizer CEO Albert Bourla Reports Acquisition of Phantom Stock Units
SEC Form 4 Filing
Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of 8 phantom stock units through the Pfizer Supplemental Savings Plan on March 15, 2024.
Summary
- On March 15, 2024, Albert Bourla, the Chairman & CEO of Pfizer Inc., acquired 8 phantom stock units through the Pfizer Supplemental Savings Plan (SSP).
- These units are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
- Following this transaction, Bourla directly owns 659,156 shares of Pfizer common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests between management and shareholders.
Stakeholder Impact
- The acquisition of phantom stock units aligns the executive's interests with those of the shareholders, potentially incentivizing performance that benefits the company's stock price.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Date of transaction: Acquisition of phantom stock units |
| 03/18/2024 | Date of report filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.